Direct health care costs of hospital admissions due to adverse events in the Netherlands

European Journal of Public Health

Volumn 24, Issue 6, 2014, Pages 1028-1033

  Magdelijns, Fabienne J H ^a   Stassen, Patricia M ^a,b   Stehouwer, Coen D A ^a,c   Pijpers, Evelien ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ECONOMICS; FEMALE; HOSPITAL COST; HUMAN; MALE; MEDICAL AUDIT; MEDICAL ERROR; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MEDICAL AUDIT; MEDICAL ERRORS; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES;

EID: 84922432224     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cku037     Document Type: Article

References (23)

1. Zegers M, de Bruijne MC, Wagner C, et al. Design of a retrospective patient record study on the occurrence of adverse events among patients in Dutch hospitals. BMC Health Serv Res 2007;7:27.
2. Hoonhout LH, de Bruijne MC, Wagner C, et al. Direct medical costs of adverse events in Dutch hospitals. BMC Health Serv Res 2009;9:27.
3. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004;170: 1678-86.
4. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991;324:370-6.
5. Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals I: occurrence and impact. N Z Med J 2002;115:U271.
6. Magdelijns FJ, Gulikers D, Pijpers E, et al. Registering complications at admission via the emergency department: an opportunity for improvement. Neth J Med 2013; 71:44-9.
7. Rottenkolber D, Schmiedl S, Rottenkolber M, et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf 2011;20:626-34.
8. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004;329:15-9.
9. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001;322:517-9.
10. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277:307-11.
11. Rodriguez-Monguio R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics 2003;21:623-50.
12. Rottenkolber D, Hasford J, Stausberg J. Costs of adverse drug events in German hospitals-a microcosting study. Value Health 2012;15:868-75.
13. European Central Bank, Eurosystem. Available at: https://http://www.ecb.europa. eu/stats/exchange/eurofxref/html/eurofxref-graph-usd.en.html (11 January 2013, date last accessed).
14. Office for National Statistics. Mid-1971 to Mid-2010 Population Estimates: United Kingdom; estimated resident population for constituent countries and regions in England. Population Demography Division, Fareham, 2011. Available at: http://www.ons.gov.uk/ons/taxonomy/search/index.html?nscl=Population+ Change&nscl-orig=Population+Change&content-type=Dataset&content-type= Reference+table&sortDirection=DESCENDING&sortBy=pubdate (4 October 2013, date last accessed).
15. Statistisches Bundesamt. Yearbook Germany Extract j Chapter 2 Population, Families, Living Arrangements 2012 Federal Statistical Office of Germany. Federal Statistical Office, Wiesbaden, 2012. Available at: https://http://www.destatis.de/EN/Publications/Specialized/Population/StatYearbook-Chapter2-5011001129004. pdf?-blob=publicationFile (4 October 2013, date last accessed).
16. Leendertse AJ, Van Den Bemt PM, Poolman JB, et al. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health 2011;14:34-40.
17. Statline Centraal Bureau voor de Statistiek. Bevolking; generatie, geslacht, leeftijd en herkomstgroepering, 1 januari, 2012. Available at: http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=37325&D1=0&D2=a&D3=0&D4=0& D5=0&D6=10&VW=T (4 October 2013, date last accessed).
18. Nederlandse Internisten Vereniging (NIV); Complicatieregistratie (E-learning). The Netherlands, 2012. Available at: http://www.internisten.nl/home/kwaliteit/complicatieregistratie/complicatieregistratie.
19. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538.
20. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002;20:443-54.
21. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek. Methoden en Standaard Kostprijzen voor Economische Evaluatie in de Gezondheidszorg. Diemen, The Netherlands: College Voor Zorgverzekeringen Geactualiseerde versie, 2010.
22. Tan SS, Bouwmans CA, Rutten FF, Hakkaart-van Roijen L. Update of the Dutch Manual for Costing in Economic Evaluations. Int J Technol Assess Health Care 2012; 28:152-8.
23. Medicijnkosten. College voor Zorgverzekeringen, 2013. Available at: http://www. medicijnkosten.nl.